Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 1 1

Status

Terminated 3Unknown 1Suspended 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1Gynecologic 1Breast 1

Conditions

Leukemia, Myeloid, Acute 41Myelodysplastic Syndromes 37Leukemia 36Leukemia, Lymphocytic, Chronic, B-Cell 27Lymphoma 26Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Multiple Myeloma 21Lymphoma, Non-Hodgkin 20Lymphoma, Follicular 20Lymphoma, Large B-Cell, Diffuse 17Lymphoma, Mantle-Cell 16Congenital Abnormalities 16Melanoma 15Lymphoma, B-Cell, Marginal Zone 14Hodgkin Disease 14Myeloproliferative Disorders 13Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13Burkitt Lymphoma 13Neoplasms, Plasma Cell 12Primary Myelofibrosis 11Leukemia, Myeloid, Accelerated Phase 11Neoplasm Metastasis 10Lymphoma, Large-Cell, Immunoblastic 9Leukemia, Myelomonocytic, Chronic 9Blast Crisis 9Anemia, Refractory, with Excess of Blasts 9Waldenstrom Macroglobulinemia 8Leukemia, Prolymphocytic 8Hematologic Neoplasms 8Graft vs Host Disease 8

Interventions

Capecitabine 27pembrolizumab 19Oxaliplatin 19Fluorouracil 17Cisplatin 17Trastuzumab 14Docetaxel 14Leucovorin 11Paclitaxel 8Irinotecan 8S 1 (combination) 7Epirubicin 6Cyclophosphamide 5tegafur-gimeracil-oteracil 4aldesleukin 4Hyperthermic Intraperitoneal Chemotherapy 4titanium silicide 3spartalizumab 3fludarabine phosphate 3fludarabine 3Surveys and Questionnaires 3Surgical Procedures, Operative 3Ramucirumab 3Nivolumab 3Indocyanine Green 3Gemcitabine 3Carboplatin 3Albumin-Bound Paclitaxel 3Ado-Trastuzumab Emtansine 3vistusertib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Stomach Neoplasms × fludarabine phosphate × Clear all
NCT03745326 2026-05-19

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients

National Institutes of Health Clinical Center (CC)

Phase 1/2 Terminated
5 enrolled 14 charts
Gastrointestinal

Colonic Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

NCT05207722 2024-12-12

CYNK-101 in Combination with Trastuzumab and Pembrolizumab in Patients with Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma

Celularity Incorporated

Phase 1/2 Terminated
1 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01212887 2012-02-28

Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer

Cancer Research UK

Phase 1 Terminated
14 enrolled
BreastGastrointestinalGynecologicThoracic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡